Treace Medical Concepts (Treace Medical Concepts) Retained Earnings : $-152.9 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Treace Medical Concepts Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Treace Medical Concepts's retained earnings for the quarter that ended in Mar. 2024 was $-152.9 Mil.

Treace Medical Concepts's quarterly retained earnings declined from Sep. 2023 ($-128.0 Mil) to Dec. 2023 ($-134.2 Mil) and declined from Dec. 2023 ($-134.2 Mil) to Mar. 2024 ($-152.9 Mil).

Treace Medical Concepts's annual retained earnings declined from Dec. 2021 ($-41.9 Mil) to Dec. 2022 ($-84.7 Mil) and declined from Dec. 2022 ($-84.7 Mil) to Dec. 2023 ($-134.2 Mil).

Treace Medical Concepts Retained Earnings Historical Data

The historical data trend for Treace Medical Concepts's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Treace Medical Concepts Retained Earnings Chart

Treace Medical Concepts Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

-17.69

-21.35

-41.91

-84.72

-134.25

Treace Medical Concepts Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Retained Earnings	Get a 7-Day Free Trial													-98.17	-110.45	-127.97	-134.25	-152.92

Treace Medical Concepts Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Treace Medical Concepts (NAS:TMCI) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Treace Medical Concepts (Treace Medical Concepts) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Treace Medical Concepts Inc (NAS:TMCI) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081

Website

https://www.treace.com

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Executives

F Barry Bays	director
Betsy Hanna	director	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE RD #150, PONTE VEDRA BEACH FL 32081
Deepti Jain	director	3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sean F. Scanlan	officer: See Remarks	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
James T Treace	director	117 BRISTOL PLACE, PONTE VEDRA BEACH FL 32082
Richard W Mott	director	1221 CROSSMAN AVENUE, SUNNYVALE CA 94089
Thomas E Timbie	director
Daniel E. Owens	officer: Chief HR Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Scot Michael Elder	officer: *See "Remarks"	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Mark Hair	officer: Chief Financial Officer	C/O RESTORATION ROBOTICS, INC., 128 BAYTECH DRIVE, SAN JOSE CA 95134
Aaron Berutti	officer: Sr. VP, Sales	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
John T. Treace	director, 10 percent owner, officer: Chief Executive Officer	C/O TREACE MEDICAL CONCEPTS, INC., 203 FORT WADE ROAD, SUITE 150, PONTE VEDRA FL 32081
Lance A Berry	director	5677 AIRLINE ROAD, ARLINGTON TN 38002
Jane E Kiernan	director	525 W ROSCOE, CHICAGO IL 60657
John R Treace	director	5677 AIRLINE RD, ARLINGTON VA 38002